Credit Suisse’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $8.47M | Buy |
123,970
+26,167
| +27% | +$1.79M | 0.01% | 999 |
|
|
2023
Q4 | $6.14M | Buy |
97,803
+11,591
| +13% | +$728K | 0.01% | 1211 |
|
|
2023
Q3 | $4.4M | Sell |
86,212
-7,443
| -8% | -$379K | ﹤0.01% | 1339 |
|
|
2023
Q2 | $4.68M | Buy |
93,655
+44,984
| +92% | +$2.25M | ﹤0.01% | 1370 |
|
|
2023
Q1 | $1.82M | Buy |
48,671
+5,666
| +13% | +$212K | ﹤0.01% | 1925 |
|
|
2022
Q4 | $2.06M | Buy |
43,005
+13,565
| +46% | +$650K | ﹤0.01% | 1840 |
|
|
2022
Q3 | $706K | Buy |
29,440
+5,543
| +23% | +$133K | ﹤0.01% | 2557 |
|
|
2022
Q2 | $520K | Buy |
23,897
+7,166
| +43% | +$156K | ﹤0.01% | 2796 |
|
|
2022
Q1 | $405K | Sell |
16,731
-359
| -2% | -$8.69K | ﹤0.01% | 3074 |
|
|
2021
Q4 | $406K | Buy |
17,090
+3,864
| +29% | +$91.8K | ﹤0.01% | 3157 |
|
|
2021
Q3 | $337K | Buy |
13,226
+1,916
| +17% | +$48.8K | ﹤0.01% | 3212 |
|
|
2021
Q2 | $254K | Sell |
11,310
-1,732
| -13% | -$38.9K | ﹤0.01% | 3348 |
|
|
2021
Q1 | $257K | Sell |
13,042
-20,694
| -61% | -$408K | ﹤0.01% | 3201 |
|
|
2020
Q4 | $895K | Buy |
+33,736
| New | +$895K | ﹤0.01% | 2635 |
|